Streptococcal toxic shock-like syndrome
- PMID: 7826100
Streptococcal toxic shock-like syndrome
Abstract
Background: After decades marked by a decrease in the incidence and severity of scarlet fever and streptococcal soft-tissue infections, invasive infections with group A streptococci have reemerged as a global public health problem. Sporadic outbreaks of a rapidly progressive disorder characterized by fever, shock, desquamating rash, and multiorgan system failure often associated with severe suppurative soft-tissue infection have recently been recognized in young, otherwise-healthy adults. Referred to as streptococcal toxic shock-like syndrome, this acute, progressive, often fatal illness appears to be related to an overall change in the virulence of group A streptococci and the reappearance of highly mucoid exotoxin-producing strains. However, the relationship between virulence factors, epidemiological features, and precise pathogenesis of these infections remains unclear.
Observations: The 80% incidence of soft-tissue involvement in streptococcal toxic shock-like syndrome and the high frequency of progression to necrotizing fasciitis, myositis, or even death are unprecedented. The type and extent of tissue injury, systemic toxicity, and multiorgan system failure associated with this syndrome appear to be mediated by streptococcal pyrogenic exotoxins via the induction of biologically potent endogenous cytokines. The observed increase in the incidence and severity of invasive group A streptococcal infections coincides with the resurgence of genetically related, highly virulent strains of Staphylococcus pyogenes that express an invasive phenotype and carry a specific gene for pyrogenic exotoxin A.
Conclusions: The changing spectrum of invasive group A streptococcal infections has prompted a reexamination of the microorganism and its diverse clinical manifestations. A clonal basis for increased virulence expression is supported epidemiologically. As the incidence of streptococcal toxic shock-like syndrome appears to be increasing, it is imperative that clinicians become familiar with the presentation of this syndrome so they can diagnose and treat it in a timely and effective manner.
Similar articles
-
Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A.N Engl J Med. 1989 Jul 6;321(1):1-7. doi: 10.1056/NEJM198907063210101. N Engl J Med. 1989. PMID: 2659990
-
Toxic shock syndrome due to group A streptococcal pharyngitis and bacteremia in an adult.J Microbiol Immunol Infect. 2008 Aug;41(4):351-4. J Microbiol Immunol Infect. 2008. PMID: 18787744
-
Toxic shock-like syndrome.Pharmacotherapy. 1992;12(1):23-7. Pharmacotherapy. 1992. PMID: 1549535 Review.
-
Toxic shock syndrome due to group A streptococcal pharyngitis and bacteremia in adults.J Microbiol Immunol Infect. 2009 Jun;42(3):276-9. J Microbiol Immunol Infect. 2009. PMID: 19812863
-
[Toxic shock-like syndrome caused by streptococci].Ned Tijdschr Geneeskd. 1999 Jul 10;143(28):1452-5. Ned Tijdschr Geneeskd. 1999. PMID: 10443259 Review. Dutch.
Cited by
-
A 13-Year-Old Boy Who Has Kawasaki Disease Shock Syndrome Presents with Parotitis.J Pediatr Intensive Care. 2020 Mar;9(1):60-63. doi: 10.1055/s-0039-1697978. Epub 2019 Oct 9. J Pediatr Intensive Care. 2020. PMID: 31984160 Free PMC article.
-
Interleukins 6 and 11 protect mice from mortality in a staphylococcal enterotoxin-induced toxic shock model.Infect Immun. 1996 Mar;64(3):714-8. doi: 10.1128/iai.64.3.714-718.1996. Infect Immun. 1996. PMID: 8641771 Free PMC article.
-
Differentiation of cultured keratinocytes promotes the adherence of Streptococcus pyogenes.J Clin Invest. 1998 Jan 1;101(1):128-36. doi: 10.1172/JCI680. J Clin Invest. 1998. PMID: 9421474 Free PMC article.
-
Bacterial superinfection in chickenpox....but it can occur at any age.BMJ. 1996 Nov 2;313(7065):1145. doi: 10.1136/bmj.313.7065.1145a. BMJ. 1996. PMID: 8916714 Free PMC article. No abstract available.
-
Prospective bacterial and fungal sources of hyaluronic acid: A review.Comput Struct Biotechnol J. 2022 Nov 10;20:6214-6236. doi: 10.1016/j.csbj.2022.11.013. eCollection 2022. Comput Struct Biotechnol J. 2022. PMID: 36420162 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials